Science Videos

from AP, Reuters, AFP, and other news services

Not to Be Sneezed at - New Allergy Vaccines Set for Clinical Trials

Date:
January 3, 2014
Source:
Reuters / Powered by NewsLook.com
Summary:
Clinical trials are set to start on a host of allergy vaccines developed by scientists in Finland. The researchers believe the trial could herald a new era of allergy treatment for millions of sufferers world-wide. Jim Drury has more.


Related Videos

last updated on 2014-12-22 at 12:43 am EST

Ebola Vaccine Trials to Start in West Africa

Ebola Vaccine Trials to Start in West Africa

AP (Nov. 12, 2014) — Dr. Anthony Fauci of the National Institute of Allergy and Infectious Diseases outlined plans Wednesday for clinical trials of a possible Ebola vaccine in West Africa and said researchers could know by the middle of 2015 if it's effective. (Nov. 12) Video provided by AP
Powered by NewsLook.com
The Hidden Universality of Food Allergy

The Hidden Universality of Food Allergy

FORA.tv (Mar. 10, 2013) — The Hidden Universality of Food Allergy Gluten Free Society - Humble Civic Center Dr. Russell M. Jaffe is Lab Director of ELISA/ACT Biotechnologies LLC and Fellow of the Health Studies Collegium. Through his expertise in non-invasive studies of cells, he developed novel tests for blood platelet survival, fibrinogen survival, platelet aggregation, and lymphocyte response (LRA by ELISA/ACT® ). He also developed the first test for traces of blood in stool that is not made falsely negative by ascorbate (vitamin C). Dr. Jaffe received his BS, Ph.D., and MD from the Boston University School of Medicine in 1972. He completed residency training in clinical chemistry at the National Institutes of Health (1973 - 1979) and is board certified in Clinical Pathology and in Chemical Pathology.
Powered by NewsLook.com
Vaccines Industry: The Competition Over Saving Lives

Vaccines Industry: The Competition Over Saving Lives

France 24 (July 8, 2013) — It's a 34 billion USD industry that's saving millions of lives, but is the money spent on vaccines going as far as it should? The market is now dominated by the public-private partnership, the Global Alliance for Vaccination and Immunization - Gavi. Working with governments and pharmaceutical companies, it's negotiated lower prices for many important vaccines. But critics say Gavi is too close to the supplier and that its purchasing decisions are being influenced by some donor countries.
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Related Stories


Share This



Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins